|
US5624813A
(en)
|
1994-04-21 |
1997-04-29 |
Mahant; Vijay K. |
NAD(P)+ /NAD(P)H based chemiluminescent diagnostics
|
|
FR2739029B1
(fr)
|
1995-09-21 |
1997-11-21 |
Roussel Uclaf |
Nouvelle application therapeutique des composes antimineralo-corticoides
|
|
AU1067697A
(en)
|
1995-12-05 |
1997-06-27 |
Jouko Antero Oikarinen |
Hsd17b1 promoter, enhancer, silencer and use thereof
|
|
US6391311B1
(en)
|
1998-03-17 |
2002-05-21 |
Genentech, Inc. |
Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
|
|
MXPA00008868A
(es)
|
1998-03-11 |
2003-04-25 |
Endorech Inc |
Inhibidores de dihidrogenasa de 17 -hidroxiesteroide y metodos para su uso.
|
|
FR2801218B1
(fr)
|
1999-11-23 |
2001-12-28 |
Hoechst Marion Roussel Inc |
Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
|
|
US20050119211A1
(en)
*
|
2001-05-18 |
2005-06-02 |
Sirna Therapeutics, Inc. |
RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA)
|
|
US20050182007A1
(en)
*
|
2001-05-18 |
2005-08-18 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA)
|
|
WO2005014811A2
(en)
*
|
2003-08-08 |
2005-02-17 |
Sirna Therapeutics, Inc. |
RNA INTERFERENCE MEDIATED INHIBITION OF XIAP GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
WO2003012052A2
(en)
|
2001-07-30 |
2003-02-13 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Specific inhibition of gene expression by small double stranded rnas
|
|
EP2305813A3
(en)
*
|
2002-11-14 |
2012-03-28 |
Dharmacon, Inc. |
Fuctional and hyperfunctional sirna
|
|
US7217807B2
(en)
*
|
2002-11-26 |
2007-05-15 |
Rosetta Genomics Ltd |
Bioinformatically detectable group of novel HIV regulatory genes and uses thereof
|
|
US7754709B2
(en)
|
2003-06-10 |
2010-07-13 |
Solvay Pharmaceuticals Bv |
Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds
|
|
US20090169585A1
(en)
|
2003-10-23 |
2009-07-02 |
Resveratrol Partners, Llc |
Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
|
|
US20050158376A1
(en)
|
2003-10-23 |
2005-07-21 |
Sardi William F. |
Dietary supplement and method of processing same
|
|
US20080299042A1
(en)
|
2004-04-30 |
2008-12-04 |
Biogen Idec Ma Inc. |
Membrane Associated Molecules
|
|
WO2005111241A2
(en)
|
2004-05-07 |
2005-11-24 |
Applera Corporation |
Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof
|
|
US8598333B2
(en)
*
|
2006-05-26 |
2013-12-03 |
Alnylam Pharmaceuticals, Inc. |
SiRNA silencing of genes expressed in cancer
|
|
FR2904000A1
(fr)
|
2006-07-19 |
2008-01-25 |
Galderma Res & Dev S N C Snc |
Modulateurs de hsd17b7 dans le traitement de l'acne ou de l'hyperseborrhee
|
|
US7951776B2
(en)
|
2006-09-01 |
2011-05-31 |
American Type Culture Collection |
Methods for treatment of type 1 diabetes
|
|
US20090203602A1
(en)
|
2006-09-01 |
2009-08-13 |
Cohava Gelber |
Compositions and methods for diagnosis and treatment of type 2 diabetes
|
|
US20080300170A1
(en)
|
2006-09-01 |
2008-12-04 |
Cohava Gelber |
Compositions and methods for diagnosis and treatment for type 2 diabetes
|
|
US20100267052A1
(en)
|
2006-09-01 |
2010-10-21 |
American Type Culture Collection |
Compositions and methods for diagnosis and treatment of type 2 diabetes
|
|
WO2008091873A2
(en)
|
2007-01-24 |
2008-07-31 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for the identification, assessment, prevention and therapy of thymic lymphoma or hamartomatous tumours
|
|
US20110150897A1
(en)
*
|
2006-10-11 |
2011-06-23 |
Meyer Thomas F |
Influenza targets
|
|
JP2010540444A
(ja)
|
2007-09-20 |
2010-12-24 |
レスベラトロル パートナーズ, エルエルシー |
遺伝子産物の濃縮または活性を調節するためのレスベラトロールを含む組成物
|
|
JPWO2009148137A1
(ja)
|
2008-06-04 |
2011-11-04 |
協和発酵キリン株式会社 |
肥満細胞の脱顆粒を制御する核酸
|
|
WO2010028110A2
(en)
|
2008-09-04 |
2010-03-11 |
Board Of Regents, The University Of Texas System |
Sequence variations in pnpla3 associated with hepatic steatosis
|
|
US20100209427A1
(en)
|
2008-09-24 |
2010-08-19 |
Yu Li |
Lysine acetylation sites
|
|
EP2177615A1
(en)
|
2008-10-10 |
2010-04-21 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Method for a genome wide identification of expression regulatory sequences and use of genes and molecules derived thereof for the diagnosis and therapy of metabolic and/or tumorous diseases
|
|
WO2010064702A1
(ja)
|
2008-12-05 |
2010-06-10 |
国立大学法人 東京大学 |
癌の予後を予測するためのバイオマーカー
|
|
US20100266618A1
(en)
|
2009-03-18 |
2010-10-21 |
Children's Hospital Of Eastern Ontario Research Institute |
Compositions and methods for augmenting activity of oncolytic viruses
|
|
US20120028816A1
(en)
|
2009-03-31 |
2012-02-02 |
Warren Stephen T |
Methods and systems for screening for and diagnosing dna methylation associated with autism spectrum disorders
|
|
US9051567B2
(en)
|
2009-06-15 |
2015-06-09 |
Tekmira Pharmaceuticals Corporation |
Methods for increasing efficacy of lipid formulated siRNA
|
|
US20120201794A1
(en)
|
2009-07-15 |
2012-08-09 |
Calimmune Inc. |
Dual vector for inhibition of human immunodeficiency virus
|
|
WO2011006214A1
(en)
|
2009-07-16 |
2011-01-20 |
Peter Maccallum Cancer Institute |
Method of detecting radiation exposure and adverse toxicity thereto
|
|
CA2781654A1
(en)
|
2009-11-25 |
2011-06-03 |
Hua Gong |
Novel genomic biomarkers for irritable bowel syndrome diagnosis
|
|
WO2011084747A2
(en)
|
2009-12-21 |
2011-07-14 |
The Johns Hopkins University |
Compositions and methods for somatic tissue induced pluripotent stem cells having an endoderm origin
|
|
WO2011127561A1
(en)
|
2010-04-12 |
2011-10-20 |
University Health Network |
Methods and compositions for diagnosing pulmonary fibrosis subtypes and assessing the risk of primary graft dysfunction after lung transplantation
|
|
WO2011128096A1
(en)
|
2010-04-16 |
2011-10-20 |
Roche Diagnostics Gmbh |
Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
|
|
DK2569446T3
(en)
|
2010-05-12 |
2018-10-29 |
Steven E Schutzer |
DIAGNOSTIC MARKERS FOR NEUROPsychiatric Disease
|
|
US8945847B2
(en)
|
2010-05-24 |
2015-02-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and kits for ascertaining biosafety of an agent
|
|
US20120058088A1
(en)
|
2010-06-28 |
2012-03-08 |
Resveratrol Partners, Llc |
Resveratrol-Containing Compositions And Methods Of Use
|
|
WO2012009547A2
(en)
|
2010-07-14 |
2012-01-19 |
The Regents Of The University Of California |
Biomarkers for diagnosis of transient ischemic attacks
|
|
WO2012031008A2
(en)
|
2010-08-31 |
2012-03-08 |
The General Hospital Corporation |
Cancer-related biological materials in microvesicles
|
|
WO2012052953A1
(en)
|
2010-10-20 |
2012-04-26 |
Fondazione Centro San Raffaele Del Monte Tabor |
MiRNA
|
|
US9617514B2
(en)
|
2010-10-26 |
2017-04-11 |
Buck Institute For Research On Aging |
Downregulation of SINE/ALU retrotransposon transcription to induce or restore proliferative capacity and/or pluripotency to a stem cell
|
|
US9920317B2
(en)
|
2010-11-12 |
2018-03-20 |
The General Hospital Corporation |
Polycomb-associated non-coding RNAs
|
|
EP3702460A1
(en)
|
2010-11-12 |
2020-09-02 |
The General Hospital Corporation |
Polycomb-associated non-coding rnas
|
|
WO2012070014A2
(en)
|
2010-11-26 |
2012-05-31 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Identification of novel cell surface markers for pancreatic progenitor cells and definite endodermal cells
|
|
EP2652149A2
(en)
|
2010-12-16 |
2013-10-23 |
Norwegian University of Science and Technology (NTNU) |
Single nucleotide polymorphism associated with risk of insulin resistance development
|
|
AU2011349464B2
(en)
|
2010-12-20 |
2016-07-07 |
The General Hospital Corporation |
Polycomb-associated non-coding RNAS
|
|
EP2704728A4
(en)
|
2011-05-03 |
2015-04-22 |
Dermachip Inc |
EXPRESSION SIGNATURES OF AGENTS ASSOCIATED WITH SKIN AGING AND GEN NETWORKS
|
|
GB201112246D0
(en)
|
2011-07-15 |
2011-08-31 |
Univ Birmingham |
Diagnosis of alzheimer's disease
|
|
US20130079241A1
(en)
|
2011-09-15 |
2013-03-28 |
Jianhua Luo |
Methods for Diagnosing Prostate Cancer and Predicting Prostate Cancer Relapse
|
|
US9796974B2
(en)
|
2011-11-18 |
2017-10-24 |
Alnylam Pharmaceuticals, Inc. |
Modified RNAi agents
|
|
WO2013126565A1
(en)
|
2012-02-24 |
2013-08-29 |
Lunyak Victoria V |
Downregulation of sine/alu retrotransposon transcription to induce or restore proliferative capacity and/or pluripotency to a stem cell
|
|
US9133461B2
(en)
|
2012-04-10 |
2015-09-15 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of the ALAS1 gene
|
|
WO2013166264A2
(en)
|
2012-05-02 |
2013-11-07 |
University Of Georgia Research Foundation, Inc. |
Methods for altering virus replication
|
|
WO2013177060A2
(en)
|
2012-05-20 |
2013-11-28 |
Trustees Of Boston University |
Methods and systems for monitoring, diagnosing, and treating chronic obstructive polmonary disease
|
|
ES2728782T3
(es)
|
2012-05-25 |
2019-10-28 |
Univ California |
Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
|
|
US20150147761A1
(en)
|
2012-06-20 |
2015-05-28 |
Helmut E. Meyer |
Specific biomarkers for hepatocellular carcinoma (hcc)
|
|
US20140004153A1
(en)
|
2012-07-02 |
2014-01-02 |
Lancell, L.L.C. |
Use of somatic mutations in the extracellular domain of transmembrane proteins in a patient's tumor as immunogens for active humoral immunotherapy of cancer
|
|
US9526720B2
(en)
|
2012-08-17 |
2016-12-27 |
The Broad Institute, Inc. |
Modulators of hepatic lipoprotein metabolism
|
|
PL2900270T3
(pl)
|
2012-09-26 |
2019-09-30 |
Tangent Reprofiling Limited |
Połączenie benzo(izo)oksazolopiperydyn ze sprzężonym kwasem linolowym
|
|
US9375433B2
(en)
|
2012-09-26 |
2016-06-28 |
Tangent Reprofiling Limited |
Modulators of androgen synthesis
|
|
BR112015013105B1
(pt)
|
2012-12-05 |
2022-02-08 |
Alnylam Pharmaceuticals, Inc |
Agente de rnai de fita dupla capaz de inibir a expressão de pcsk9, seus usos, composição farmacêutica e método de inibição da expressão de pcsk9 em uma célula in vitro
|
|
US20150366997A1
(en)
|
2012-12-07 |
2015-12-24 |
Shire Human Genetics Therapies, Inc. |
COMPOSITIONS AND METHODS FOR mRNA DELIVERY
|
|
WO2014152940A1
(en)
|
2013-03-14 |
2014-09-25 |
Shire Human Genetic Therapies, Inc. |
Mrna therapeutic compositions and use to treat diseases and disorders
|
|
WO2014159443A1
(en)
|
2013-03-14 |
2014-10-02 |
Genomedx Biosciences, Inc. |
Cancer biomarkers and classifiers and uses thereof
|
|
EP4219761A1
(en)
|
2013-03-15 |
2023-08-02 |
Veracyte, Inc. |
Biomarkers for diagnosis of lung diseases and methods of use thereof
|
|
US20140329704A1
(en)
|
2013-03-28 |
2014-11-06 |
President And Fellows Of Harvard College |
Markers for mature beta-cells and methods of using the same
|
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
|
AU2014268529C1
(en)
|
2013-05-22 |
2020-10-01 |
Alnylam Pharmaceuticals, Inc. |
TMPRSS6 iRNA compositions and methods of use thereof
|
|
EP3004376B1
(en)
|
2013-06-03 |
2018-05-09 |
Nestec S.A. |
Methods for diagnosing chronic valvular disease
|
|
WO2014197453A1
(en)
|
2013-06-03 |
2014-12-11 |
The Trustees Of Columbia University In The City Of New York |
Recurrent mutations in epigenetic regulators, rhoa and fyn kinase in peripheral t-cell lymphomas
|
|
SG11201510327TA
(en)
|
2013-06-17 |
2016-01-28 |
Broad Inst Inc |
Delivery, engineering and optimization of systems, methods and compositions for targeting and modeling diseases and disorders of post mitotic cells
|
|
JP6738728B2
(ja)
|
2013-06-17 |
2020-08-19 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
肝臓ターゲティングおよび治療のためのCRISPR−Cas系、ベクターおよび組成物の送達および使用
|
|
US20150079061A1
(en)
|
2013-07-12 |
2015-03-19 |
Patrick J. Casey |
Method for the harvesting, processing, and storage of proteins from the mammalian feto-placental unit and use of such proteins in compositions and medical treatment
|
|
US20150079062A1
(en)
|
2013-07-12 |
2015-03-19 |
Patrick J. Casey |
Method for harvesting, processing, and storage of proteins from the mammalian feto-placental unit and use of such proteins in compositions and medical treatment
|
|
RU2545990C2
(ru)
|
2013-07-16 |
2015-04-10 |
Государственное бюджетное учреждение здравоохранения города Москвы Московский клинический научно-практический центр Департамента здравоохранения города Москвы |
Способ дифференциальной диагностики стеатоза печени и стеатогепатита
|
|
ES3032935T3
(en)
|
2013-10-22 |
2025-07-29 |
Translate Bio Inc |
Lipid formulations for delivery of messenger rna
|
|
CN103520724B
(zh)
*
|
2013-10-23 |
2016-05-25 |
江苏美迪森生物医药有限公司 |
Hsd17b13蛋白或其编码基因的抑制剂的新用途
|
|
GB201320061D0
(en)
|
2013-11-13 |
2013-12-25 |
Electrophoretics Ltd |
Materials nad methods for diagnosis and prognosis of liver cancer
|
|
AU2015257594A1
(en)
|
2014-05-09 |
2016-11-24 |
Tangent Reprofiling Limited |
Modulators of androgen synthesis
|
|
WO2015191693A2
(en)
|
2014-06-10 |
2015-12-17 |
Massachusetts Institute Of Technology |
Method for gene editing
|
|
US10588980B2
(en)
|
2014-06-23 |
2020-03-17 |
Novartis Ag |
Fatty acids and their use in conjugation to biomolecules
|
|
WO2016004387A1
(en)
|
2014-07-02 |
2016-01-07 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Gene expression signature for cancer prognosis
|
|
WO2016009246A1
(en)
|
2014-07-14 |
2016-01-21 |
Casey Patrick J |
Method for the harvesting, processing, and storage of proteins from the mammalian feto-placental unit and use of such proteins in compositions and medical treatment
|
|
WO2016028638A1
(en)
|
2014-08-18 |
2016-02-25 |
Drexel University |
Methods, computer-readable media, and systems for assessing samples and wounds, predicting whether a wound will heal, and monitoring effectiveness of a treatment
|
|
CN114606309A
(zh)
|
2014-11-05 |
2022-06-10 |
威拉赛特公司 |
使用机器学习和高维转录数据的诊断系统和方法
|
|
JP2018510621A
(ja)
|
2015-02-13 |
2018-04-19 |
アルナイラム ファーマシューティカルズ, インコーポレイテッドAlnylam Pharmaceuticals, Inc. |
パタチン様ホスホリパーゼドメイン含有3(PNPLA3)iRNA組成物およびその使用方法
|
|
CN104698108B
(zh)
|
2015-03-26 |
2016-11-09 |
中国药科大学 |
一种利用固定化酶筛选I型17β羟类固醇脱氢酶抑制剂的方法
|
|
WO2017048620A1
(en)
|
2015-09-14 |
2017-03-23 |
Alnylam Pharmaceuticals, Inc. |
Polynucleotide agents targeting patatin-like phospholipase domain containing 3 (pnpla3) and methods of use thereof
|
|
EP3159407A1
(en)
|
2015-10-23 |
2017-04-26 |
Silence Therapeutics (London) Ltd |
Guide rnas, methods and uses
|
|
EP3387129A1
(en)
|
2015-12-10 |
2018-10-17 |
Alnylam Pharmaceuticals, Inc. |
STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) CHAPERONE (SCAP) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
|
|
EP3389671A4
(en)
|
2015-12-14 |
2019-07-17 |
Cold Spring Harbor Laboratory |
ANTISENSE OLIGOMERS FOR THE TREATMENT OF ALAGILLE SYNDROME
|
|
WO2017106283A1
(en)
|
2015-12-14 |
2017-06-22 |
Cold Spring Harbor Laboratory |
Compositions and methods for treatment of liver diseases
|
|
CA3005131A1
(en)
|
2015-12-14 |
2017-06-22 |
Cold Spring Harbor Laboratory |
Antisense oligomers for treatment of tuberous sclerosis complex
|
|
ES2903394T3
(es)
|
2015-12-14 |
2022-04-01 |
Cold Spring Harbor Laboratory |
Composiciones para el tratamiento de la retinitis pigmentosa 13
|
|
WO2017106382A1
(en)
|
2015-12-14 |
2017-06-22 |
Cold Spring Harbor Laboratory |
Compositions and methods for treatment of central nervous system diseases
|
|
JP7036723B2
(ja)
|
2015-12-14 |
2022-03-15 |
コールド スプリング ハーバー ラボラトリー |
眼疾患の処置のための組成物および方法
|
|
JP7049247B2
(ja)
|
2015-12-14 |
2022-04-06 |
コールド スプリング ハーバー ラボラトリー |
腎臓病の処置のための組成物と方法
|
|
WO2017156310A1
(en)
|
2016-03-09 |
2017-09-14 |
Molecular Stethoscope, Inc. |
Methods and systems for detecting tissue conditions
|
|
US11124460B2
(en)
|
2016-03-16 |
2021-09-21 |
Spogen Biotech Inc. |
Methods for promoting plant health using free enzymes and microorganisms that overexpress enzymes
|
|
WO2017191274A2
(en)
|
2016-05-04 |
2017-11-09 |
Curevac Ag |
Rna encoding a therapeutic protein
|
|
US10036024B2
(en)
|
2016-06-03 |
2018-07-31 |
Purdue Research Foundation |
siRNA compositions that specifically downregulate expression of a variant of the PNPLA3 gene and methods of use thereof for treating a chronic liver disease or alcoholic liver disease (ALD)
|
|
GB201609977D0
(en)
|
2016-06-08 |
2016-07-20 |
Cancer Rec Tech Ltd |
Chemosensitivity predictive biomarkers
|
|
US10767175B2
(en)
|
2016-06-08 |
2020-09-08 |
Agilent Technologies, Inc. |
High specificity genome editing using chemically modified guide RNAs
|
|
TW202313978A
(zh)
*
|
2016-11-23 |
2023-04-01 |
美商阿尼拉製藥公司 |
絲胺酸蛋白酶抑制因子A1 iRNA組成物及其使用方法
|
|
EP3551757A1
(en)
|
2016-12-08 |
2019-10-16 |
Intellia Therapeutics, Inc. |
Modified guide rnas
|
|
US20180185516A1
(en)
|
2016-12-09 |
2018-07-05 |
Sangamo Therapeutics, Inc. |
Delivery of target specific nucleases
|
|
RU2019121801A
(ru)
|
2016-12-14 |
2021-01-15 |
Лигандал, Инк. |
Композиции и способы для доставки полезной нагрузки в виде нуклеиновой кислоты и/или белка
|
|
CA3049980A1
(en)
|
2017-01-23 |
2018-07-26 |
Regeneron Pharmaceuticals, Inc. |
Hydroxysteroid 17-beta dehydrogenase 13 (hsd17b13) variants and uses thereof
|
|
EP3635121A1
(en)
|
2017-06-02 |
2020-04-15 |
Institut National de la Sante et de la Recherche Medicale (INSERM) |
Viral vector combining gene therapy and genome editing approaches for gene therapy of genetic disorders
|
|
AU2018348195B2
(en)
|
2017-10-11 |
2025-05-15 |
Regeneron Pharmaceuticals, Inc. |
Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation
|
|
MY207352A
(en)
|
2018-03-21 |
2025-02-21 |
Regeneron Pharma |
17-hydroxysteroid dehydrogenase type 13 (hsd17b13) irna compositions and methods of use thereof
|
|
US20210000906A1
(en)
|
2018-03-21 |
2021-01-07 |
Ionis Pharmaceuticals, Inc. |
Modulation of hsd17b13 expression
|
|
US11690921B2
(en)
|
2018-05-18 |
2023-07-04 |
Sangamo Therapeutics, Inc. |
Delivery of target specific nucleases
|
|
JP7832761B2
(ja)
|
2018-06-08 |
2026-03-18 |
インテリア セラピューティクス,インコーポレイテッド |
遺伝子編集のための修飾されたガイドrna
|
|
GB2596224B
(en)
|
2018-06-19 |
2022-09-07 |
Univ Texas |
Lipid nanoparticle compositions for delivery of mRNA and long nucleic acids
|
|
US12534728B2
(en)
*
|
2018-09-19 |
2026-01-27 |
Arrowhead Pharmaceuticals, Inc. |
RNAi agents for inhibiting expression of 17beta-HSD type 13 (HSD17B13), compositions thereof, and methods of use
|
|
CA3160657A1
(en)
*
|
2019-11-08 |
2021-05-14 |
Phio Pharmaceuticals Corp. |
Chemically modified oligonucleotides targeting bromodomain containing protein 4 (brd4) for immunotherapy
|
|
JP2023515974A
(ja)
*
|
2020-02-28 |
2023-04-17 |
アイオーニス ファーマシューティカルズ, インコーポレーテッド |
Scn1a発現を調節するための化合物及び方法
|
|
CA3197198A1
(en)
*
|
2020-11-04 |
2022-05-12 |
Ute SCHAEPER |
Nucleic acids for inhibiting expression of pros1 in a cell
|